Covid-19 roundup: GSK and Vir reach sotro­vimab sup­ply agree­ment in Sin­ga­pore; J&J vac­cine shows var­ied suc­cess against vari­ants

GSK Sin­ga­pore and Vir Biotech­nol­o­gy have reached an agree­ment with the Sin­ga­pore gov­ern­ment to sup­ply it with a sin­gle-dose mon­o­clon­al an­ti­body for Covid-19.

GSK has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER